Funded by Hooters of America, LLC
While breast cancer in the United States is highest in white women, the mortality and incidence of more virulent forms of cancer are higher in black women. An under- representation of black women in clinical trials prevents a full understanding of how new drugs will potentially affect them and limits our effectiveness in treating future black women with breast cancer. The purpose of this research is to identify the specific reasons for low enrollment of black women in breast cancer trials in southeast Louisiana and develop means of addressing the barriers to participation.